Safety of therapeutic methylphenidate in adults: A systematic review of the evidence

Journal of Psychopharmacology

Volumn 23, Issue 2, 2009, Pages 194-205

  Godfrey, J ^a  

^a Westhaven and Portland CMHT   (United Kingdom)

Author keywords

Adverse effects; Attention deficit hyperactivity disorder; Methylphenidate; Substance misuse; Therapeutic use

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ABDOMINAL PAIN; ADULT; AGITATION; AKATHISIA; ANOREXIA; ANXIETY; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR SYMPTOM; CLINICAL TRIAL; CONSTIPATION; DECREASED APPETITE; DEPRESSION; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG MISUSE; DRUG SAFETY; DRUG TOLERABILITY; EUPHORIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HEART RATE; HEARTBURN; HUMAN; HYPERACTIVITY; INSOMNIA; IRRITABILITY; LONG TERM CARE; MENSTRUATION DISORDER; MENTAL STRESS; MOOD CHANGE; MOOD DISORDER; MUSCLE CRAMP; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PRURITUS; RASH; RECREATION; RESTLESSNESS; REVIEW; SEXUAL DYSFUNCTION; SHORT COURSE THERAPY; SIDE EFFECT; SKIN DISEASE; SLEEP DISORDER; SLURRED SPEECH; STOMACH PAIN; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THORAX PAIN; TIC; TREMOR; URINARY TRACT DISEASE; VERTIGO; VOMITING; WEIGHT REDUCTION; XEROSTOMIA; ADDICTION; EVIDENCE BASED MEDICINE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; EVIDENCE-BASED MEDICINE; HUMANS; METHYLPHENIDATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 67651171707     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089809     Document Type: Review

References (78)

1. ABPI (2006) Medicines Compendium 2006. Datapharm Communications Ltd. Leatherhead, Surrey.
2. Alban JP, Hopson MM, Ly V, Whyte J, (2004) Effect of methylphenidate on vital signs and adverse effects in adults with traumatic brain injury. Am J Phys Med Rehabil 8: 131 - 137.
3. Asherson P, Chen W, Craddock B, Taylor E, (2007) Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 190: 4 - 5.
4. Ashton H, Gallagher P, Moore B, (2006) The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol 20: 602 - 610.
5. Babcock Q, Byrne T, (2000) Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 49: 143 - 145.
6. Barrett SP, Darredeau C, Bordy LE, Pihl RO, (2005) Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry 50: 457 - 461.
7. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T, (2006) A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 59: 829 - 835.
8. Blockmans D; ,Persoons P; ,Van-Houdenhove B; ,Bobbaers H; , (2006) Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 119: 167.e23-167.e30.
9. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F, (2003) The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry 48: 546 - 554.
10. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J, (2001) A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 161: 411 - 420.
11. Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL, (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24: 2073 - 2078.
12. Carpenter MD, Winsberg BG, Camus LA, (1992) Methylphenidate augmentation therapy in schizophrenia. J Clin Psychopharmacol 12: 273 - 275.
13. Carpentier PJ, de-Jong CAJ, Dijkstra BAG, Verbrugge CAJ, Krabbe PFM, (2005) A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 100: 1868 - 1874.
14. Center for the Evaluation of Risks to Human Reproduction (2005) NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methylphenidate. NIH Publication 05-4473. National Institutes of Health, Bethesda, Maryland.
15. Cherland E, Fitzpatrick R, (1999) Psychotic side effects of psychostimulants: a 5-year review. Can J Psychiatry 44: 811 - 813.
16. Chillar RK, Jackson AL, Alaan L, (1982) Hemiplegia after intracarotid injection of methylphenidate. Arch Neurol 39: 598 - 599.
17. Coetzee M, Kaminer Y, Morales A, (2002) Megadose intranasal methylphenidate (Ritalin) abuse in adult attention deficit hyperactivity disorder. Subst Abus 23: 165 - 169.
18. Curran C, Byrappa N, McBride A, (2004) Stimulant psychosis: systematic review. Br J Psychiatry 185: 196 - 204.
19. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J, (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24: 24 - 29.
20. Faraone SV, Biederman J, (2005) What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord 9: 384 - 391.
21. Faraone SV, Biederman J, Mick E, (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36: 159 - 165.
22. Garland EJ, (1998) Intranasal abuse of prescribed methylphenidate. J Am Acad Child Adolesc Psychiatry 37: 573 - 574.
23. Gelperin K; ,Brinker AD; ,Avignan MI; , (2006) MedWatch reporting of death, sudden death, and cardiovascular events in association with stimulants used in the treatment of ADHD over a recent 5-year period. Presentation, 12th Annual FDA Science Forum, 18-20 April 2006.
24. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B, (1998) Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 79: 1047 - 1050.
25. Gualtieri CT, Evans RW, (1988) Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj 2: 273 - 290.
26. Haglund R, Howerton L, (1982) Ritalin: consequences of abuse in a clinical population. Int J Addict 17: 349 - 356.
27. Hall KM, Irwin MM, Bowman KA, Frankenburger W, Jewett DC, (2005) Illicit use of prescribed stimulant medication among college students. J Am Coll Health 54: 167 - 174.
28. Iversen L, (2006) Speed, Ecstasy, Ritalin. The Science of the Amfetamines. Oxford University Press. Oxford.
29. Jaffe SL, (1991) Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 30: 773 - 775.
30. Kaelin DL, Cifu DX, Matthies B, (1996) Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Physical Med Rehabil 77: 6 - 9.
31. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM, (2006) Prevalence of adult ADHD in the United States: results from the National Comorbidity Survey Replication (NCS-R). Am J Psychiatry 163: 716 - 723.
32. Kooij JJS, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK, (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 34: 973 - 982.
33. Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP, (2005) Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 35: 817 - 827.
34. Kollins SH, MacDonald EK, Rush CR, (2001) Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 68: 611 - 627.
35. Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS, (2001) Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 13: 129 - 134.
36. Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S, (2004) International consensus statement on attention-deficit/ hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs). clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14: 11 - 28.
37. Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS, (2005) Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol 20: 97 - 104.
38. Leonard BE, McCartan D, White J, King DJ, (2004) Mathylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 19: 151 - 180.
39. Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV, (2006) Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend 81: 137 - 148.
40. Levin ED, Conners CK, Silva D, Canu W, March J, (2001) Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 9: 83 - 90.
41. Levine B, Caplan YH, Kauffman G, (1986) Fatality resulting from methylphenidate overdose. J Anal Toxicol 10: 209 - 210.
42. Low K, Gendaszek E, (2002) Illicit use of psychostimulants among college students: a preliminary study. Psychol Health Med 7: 283 - 287.
43. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J, (1990) Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765 - 774.
44. Massello W, Carpenter DA, (1999) A fatality due to the intranasal abuse of methylphenidate (Ritalin). J Forensic Sci 44: 220 - 221.
45. Mattes JA, Boswell L, Oliver H, (1984) Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch General Psychiatry 41: 1059 - 1063.
46. Mattes J, (1985) Methylphenidate in mild depression: a double-blind controlled trial. J Clin Psychiatry 46: 525 - 527.
47. McCabe SE, Knight JR, Teter CJ, Wechsler H, (2005) Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 100: 96 - 106.
48. McCabe SE, Teter CJ, Boyd CJ, (2006) Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health 54: 269 - 278.
49. McGough JJ, Barkley RA, (2004) Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatr 161: 1948 - 1956.
50. McFadyen-Leussis MP, Lewis SP, Bond TLY, Carrey N, Brown RE, (2004) Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in mice. Pharmacol Biochem Behav 77: 491 - 500.
51. Mooney GF, Haas LJ, (1993) Effect of methylphenidate on brain injury-related anger. Arch Phys Med Rehabil 74: 153 - 160.
52. NICE (2006) Technology Appraisal 98. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Review of Technology Appraisal 13.
53. Nissen (2006) ADHD drugs and cardiovascular risk. New Engl J Med 354: 1445-1448.
54. Novak SP, Ball JK, (2006) Emergency department visits involving ADHD stimulant medication. In: The DAWN report (issue 29). Office of Applied Statistics, Substance Abuse and Mental Health Services Administration. Rockwille, Maryland.
55. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, Weiss M, Young S, (2007) Evidence-based guidelines for management of attention-deficit hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association of Psychopharmacology. J Psychopharmacol 21: 10 - 41.
56. Pawluck LK, Hurwitz TD, Schluter JL, Ullevig C, Mahowald MW, (1995) Psychiatric morbidity in narcoleptics on chronic high dose methylphenidate therapy. J Nerv Ment Dis 183: 45 - 48.
57. Plenger PM, Dixon CE, Castillo RM, Frankowski RF, Yablon SA, Levin HS, (1996) Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil 77: 536 - 540.
58. Ross DC, Fischhoff J, Davenport B, (2002) Treatment of ADHD when tolerance to methylphenidate develops. Psychiatr Serv 53: 102.
59. Ross R, (2006) Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 163: 1149 - 1152.
60. Safer DJ, Allen RP, (1989) Absence of tolerance to the behavioural effects of methylphenidate in hyperactive and inattentive children. J Pediatr 115: 1003 - 1008.
61. Schatz H, Drake M, (1979) Self-injected retinal emboli. Ophthalmology 86: 468 - 483.
62. Sadeghian H, (2004) Lacunar stroke associated with methylphenidate abuse. Can J Neurol Sci 31: 109 - 111.
63. Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR, Lockhart N, Edwards A, Donlin J, Pihlgren E, (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10: 286 - 294.
64. Speech TJ, Rao SM, Osmon DC, Sperry LT, (1993) A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj 7: 333 - 338.
65. Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K, (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 52: 434 - 443.
66. Spencer T; ,Biederman J; , (2004) Efficacy in a six-month trial of methylphenidate in adults with ADHD. Poster Presentation, ECNP October 2004.
67. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S, (2005) A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 456 - 463.
68. Stein MA, (2003) OROS methylphenidate for treatment of adolescents and adults with ADHD. Poster Presentation at 50th Anniversary Meeting of the American Academy of Child and Adolescent Psychiatry, Miami, Florida 14-19 October 2003.
69. Stern EJ, Frank MS, Schmutz JF, Glenny RW, Schmidt RA, Godwin JD, (1994) Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin). findings on chest radiographs and CT scans. Am J Roentgenol 162: 555 - 560.
70. Stecyk O, Loludice TA, Demeter S, Jacobs J, (1985) Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 14: 597 - 599.
71. Tenenbaum S, Paull JC, Sparrow EP, Dodd DK, Green L, (2002) An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). J Atten Disord 6: 49 - 60.
72. Teter CJ, McCabe SE, Boyd CJ, Guthrie SK, (2003) Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy 23: 609 - 617.
73. Upadhyaya HP, Rose K, Wang W,. O-Rourke, K, Sullivan, B, Deas, D, Brady, KT (2005) Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol 15: 799 - 809.
74. van Dyck CH, McMahon TJ, Rosen MI, O'Malley SS, O'Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR, (1997) Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study. J Neuropsychiatry Clin Neurosci 9: 29 - 36.
75. Wender PH, Reimherr FW, Wood D, Ward M, (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142: 547 - 552.
76. White BP, Becker-Blease KA, Grace-Bishop K, (2006) Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health 54: 261 - 268.
77. Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H, (2005) Blood pressure changes associated with medication treatment of adults with attention-deficit/ hyperactivity disorder. J Clin Psychiatry 66: 253 - 259.
78. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J, (2006) Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry 45: 408 - 414.